WELLNEO SUGAR Co., Ltd. (TYO:2117)

Market Cap	76.48B
Revenue (ttm)	97.07B
Net Income (ttm)	5.57B
Shares Out	32.74M
EPS (ttm)	170.05
PE Ratio	13.74
Forward PE	n/a
Dividend	108.00 (4.68%)
Ex-Dividend Date	Sep 29, 2025

Volume	54,300
Average Volume	32,680
Open	2,313.00
Previous Close	2,307.00
Day's Range	2,310.00 - 2,346.00
52-Week Range	1,860.00 - 2,438.00
Beta	-0.06
RSI	70.48
Earnings Date	Aug 5, 2025

About Ligand Pharmaceuticals

WELLNEO SUGAR Co., Ltd. manufactures and sells sugar and other food products primarily in Japan. It operates in Sugar Business and Food & Wellness segments. The Sugar business segment offers sugar under the Cup, Kururu, and SEVEN brand names. The Food & Wellness segment provides functional materials, food additives, edible films, and sugar-derived, and sweetener-related products, as well as operates gym. It also operates a refrigerated warehouse and warehousing business for storage, cargo handling, and harbor transportation services. The compan...

• Industry: Food Confectioners
• Sector: Consumer Staples
• Founded: 2011
• Employees: 739
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 2117

Financial Performance

In 2024, WELLNEO SUGAR's revenue was 97.07 billion, an increase of 5.29% compared to the previous year's 92.19 billion. Earnings were 5.57 billion, an increase of 0.74%.